Laguna-Bárcenas SC, Valdelamar-Dehesa A, Carrillo-Pacheco E, Pichardo-Bahena R

Language: Spanish
References: 6
Page: 372-379
PDF size: 281.86 Kb.

ABSTRACT

Background: Neurofibromatosis type 1 is an autosomal dominant hereditary disease that affects multiple systems presenting various manifestations: neurological, vascular and dermatological, within which are neurofibromas. Neurofibromas are benign tumors and there are several types. They can appear in different locations; including the facial and parotid region, which may be a reason for consultation with the ENT doctor. The differentiation between the subtypes in patients with multiple neurofibromas is important because, in addition to the aesthetic impact, they may present with other types of deficits and manifestations depending on their location and the involvement of surrounding structures. There is controversy regarding its treatment, and the best time to perform it; however, it is important distinguishing among the different histological subtypes, due to their particularities, to determine the best treatment and follow-up in patients with type 1 neurofibromatosis.
Clinical cases: A 31-year old female patient with a parotid right plexiform neurofibroma.
Conclusions: Distinguishing the neurofibroma subtype in patients with NF1 is of utmost importance, as it will determine the best treatment option and, if necessary, have a close follow-up of the evolution if a plexiform neurofibroma is suspected.

REFERENCES

1. Anderson JL, Gutmann DH. Neurofibromatosis type 1. En: Handbook of Clinical Neurology. Elsevier; 2015: 75-86.

2. Cimino PJ, Gutmann DH. Neurofibromatosis type 1. En: Handbook of Clinical Neurology. Elsevier; 2018: 799-811.

3. Hirbe AC, Gutmann DH. Neurofibromatosis type 1: a multidisciplinary approach to care. Lancet Neurol 2014; 13 (8): 834-43. doi: 10.1016/S1474-4422(14)70063-8.

4. Korf, Bruce R. Plexiform neurofibromas. Am J Med Gen 1999; 89 (1): 31-37. doi: 10.1002/(sici)1096- 8628(19990326)89:1<31::aid-ajmg7>3.0.co;2-w.

5. Overdiek A, Feifel H, Schaper J, Mayatepek E, Rosenbaum T. Diagnostic delay of NF1 in hemifacial hypertrophy due to plexiform neurofibromas. Brain Dev 2006; 28 (5): 275-80. doi: 10.1016/j.braindev.2005.10.001.

6. Blioskas S, Sotiriou S, Rizou K, Koletsa T, Karkos P, Kalogera- Fountzila A, et al. An exceptional case of intraparotid plexiform neurofibroma originating from autonomic fibers of the auriculotemporal nerve. Case Rep Med 2017; 2017: 1-5. doi: 10.1155/2017/8327215.